ACMI VISTA CTR BIPOLAR LOOP ELECTRODE

K031001 · Acmi Corporation · FAS · May 21, 2003 · Gastroenterology, Urology

Device Facts

Record IDK031001
Device NameACMI VISTA CTR BIPOLAR LOOP ELECTRODE
ApplicantAcmi Corporation
Product CodeFAS · Gastroenterology, Urology
Decision DateMay 21, 2003
DecisionSESE
Submission TypeSpecial
Regulation21 CFR 876.4300
Device ClassClass 2
AttributesTherapeutic

Intended Use

Intended for use in patients requiring endoscopic surgery for general urological tissue resection, ablation, and excision and hemostasis of blood vessels. These procedures include Bladder Tumor Diagnosis and Resection, Transurethral Prostatic and Bladder Biopsy, Transurethral Prostatic Resection, Removal of Ureteral Calculus, and Treatment of Vesical Neck Constriction.

Device Story

Double loop bipolar electrosurgical device; used with electrosurgical generator (controller), bipolar active cord, and resectoscope system. Operates by delivering electrical energy to tissue for cutting, coagulation, and ablation during endoscopic urological procedures. Operated by physicians in clinical settings. Device modifications include changes to two electrode materials, packaging, and sterilization method. Output is controlled by the electrosurgical generator to achieve desired tissue effect; assists surgeons in performing minimally invasive urological interventions.

Clinical Evidence

Bench testing only. No clinical data provided.

Technological Characteristics

Double loop bipolar electrosurgical electrode. Energy source: external electrosurgical generator. Connectivity: connects to bipolar resectoscope system and bipolar active cord. Sterilization: modified method (details not specified).

Indications for Use

Indicated for patients requiring endoscopic urological surgery, including tissue resection, ablation, excision, and hemostasis. Procedures include bladder tumor diagnosis/resection, transurethral prostatic/bladder biopsy, transurethral prostatic resection, ureteral calculus removal, and vesical neck constriction treatment.

Regulatory Classification

Identification

An endoscopic electrosurgical unit and accessories is a device used to perform electrosurgical procedures through an endoscope. This generic type of device includes the electrosurgical generator, patient plate, electric biopsy forceps, electrode, flexible snare, electrosurgical alarm system, electrosurgical power supply unit, electrical clamp, self-opening rigid snare, flexible suction coagulator electrode, patient return wristlet, contact jelly, adaptor to the cord for transurethral surgical instruments, the electric cord for transurethral surgical instruments, and the transurethral desiccator.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ Ko 31001 # MAY 21 2003 # 510(k) Summary of Safety and Effectiveness ACMI Corporation ACMI VISTA CTR BIPOLAR LOOP ELECTRODE (Page 1 of 2) ### General Information Manufacturer: ACMI Corporation 136 Turnpike Rd. Southborough, MA. 01772-2104 2020483 March 28, 2003 FDA Establishment Registration: Contact Person: Gabriel J. Muraca, Jr. Senior Regulatory Affairs Specialist Date Prepared: ## Device Description Classification Name: 21CFR 878.4400 -Electrosurgical cutting and coagulation device and accessories. Trade Name: Generic/Common Name: ACMI Vista CTR Bipolar Loop Electrode Electrosurgical cutting and Coagulation device and Accessories ### Predicate Devices | ACMI USA Elite System Right Angle Cutting Loop Electrode | K973820 | |----------------------------------------------------------|---------| | ACMI Bipolar Resectoscope & Loop Electrode | K021166 | ### Intended Uses Intended for use in patients requiring endoscopic surgery for general urological tissue resection, ablation, and excision and hemostasis of blood vessels. These procedures include Bladder Tumor Diagnosis and Resection, Transurethral Prostatic and Bladder Biopsy, Transurethral Prostatic Resection, Removal of Ureteral Calculus, and Treatment of Vesical Neck Constriction. {1}------------------------------------------------ 510(k) Summary of Safety and Effectiveness ACMI Corporation ACMI VISTA CTR BIPOLAR LOOP ELECTRODE (Page 2 of 2) # Product Description The Vista CTR Bipolar Loop Electrode is a double loop bipolar electrosurgical device, designed to work with currently marketed Electrosurgery Systems. These systems consist of an electrosurgical generator (the Controller), a reusable or disposable Cable (Bipolar Active Cord) and a Bipolar Resectoscope System. ## Summary of Safety and Effectiveness This Special 510(k) proposes a modification in two materials of the electrode, a change in the packaging, sterilization method, and a change in the labeling to indicate the new sterilization method. The indications for use, principles of operation, of the Vista CTR Bipolar Loop Electrode remain the same as in the predicate devices. The proposed modifications for the Vista CTR Bipolar Loop Electrode, as described in this submission, are substantially equivalent to the predicate devices. The proposed modification in materials, packaging, sterilization, and labeling are not substantial changes or modifications, and do not significantly affect the safety or efficacy of the devices. {2}------------------------------------------------ Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized representation of a human figure, with three overlapping profiles suggesting a sense of community and support. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 MAY 21 2003 Gabriel J. Muraca, Jr. Senior Regulatory Affairs Specialist ACMI Corporation 136 Turnpike Road SOUTHBOROUGH MA 01772-2104 Re: K031001 Trade/Device Name: ACMI® Vista CTR Bipolar Loop Electrode Regulation Number: 21 CFR §876.4300 Regulation Name: Endoscopic electrosurgical unit and accessories Regulatory Class: II Product Code: 78 FAS Dated: April 30, 2003 Received: May 1, 2003 Dear Mr. Muraca: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (sections 531-542 of the Act); 21 CFR 1000-1050. {3}------------------------------------------------ This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at one of the following numbers, based on the regulation number at the top of this letter: | 8xx.1xxx | (301) 594-4591 | |----------------------------------|----------------| | 876.2xxx, 3xxx, 4xxx, 5xxx | (301) 594-4616 | | 884.2xxx, 3xxx, 4xxx, 5xxx, 6xxx | (301) 594-4616 | | 892.2xxx, 3xxx, 4xxx, 5xxx | (301) 594-4654 | | Other | (301) 594-4692 | Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html. Sincerely yours, Nancy C Brogdon Nancy C. Brogdon Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ # Device Name: ACMI VISTA CTR BIPOLAR LOOP ELECTRODE 03/001 510(k) Number: ### Indications for Use: Intended for use in patients requiring endoscopic surgery for general urological tissue resection, ablation, and excision and hemostasis of blood vessels. These procedures include Bladder Tumor Diagnosis and Resection, Transurethral Prostatic and Bladder Biopsy, Transurethral Prostatic Resection, Removal of Ureteral Calculus, and Treatment of Vesical Neck Constriction. # (PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Prescription Use: __ X _ OR Over-the-Counter Use: (Per 21 CFR 801.109) Nancy C. Brogdon (Division (Division of Reproductive, Abdominal, and Radiological Device 510(k) Number
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%